1 results match your criteria: "Massachusetts ukayyali@tuftsmedicalcenter.org.[Affiliation]"
Anthrax lethal toxin-induced lung injury and treatment by activating MK2.
J Appl Physiol (1985)
August 2015
Pulmonary, Critical Care, and Sleep Division, Department of Medicine/Tupper Research Institute, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts
Article Synopsis
- * A rat model injected with LeTx mimics acute lung injury, providing a valuable tool to study treatments for conditions like acute respiratory distress syndrome (ARDS), which other models struggle to replicate.
- * Researchers have developed a peptide, MK2-AP, that activates a protein to enhance protective effects against LeTx, potentially offering new therapeutic strategies for anthrax and related pulmonary complications.